Effects of Ankaferd Hemostat on Helicobacter pylori strains and antibiotic resistance
Conclusion: Our present study indicated, for the first time, that ABS could act against H. pylori. ABS is clinically used for the management of GI bleeding due to benign and malignant GI lesions. Thus, the possible anti-H. pylori effect of ABS shall expand the therapeutic spectrum of the drug in GI lesions in relation to H. pylori infection such as peptic ulser disease (PUD) and lymphoid tissue (MALT) lymphomagenesis.
PMID: 30761849 [PubMed - in process]
Source: Turkish Journal of Medical Sciences - Category: General Medicine Tags: Turk J Med Sci Source Type: research
More News: Antimicrobial Resistance | Bleeding | Cancer & Oncology | Gastric Ulcer | Gastritis | Gastroenterology | General Medicine | Helicobacter Pylori | Herbs | Middle East Health | Peptic Ulcer | Study | Turkey Health